These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16966829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV.
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N, Hara H, Okamura M, Egusa G, Yamakido M.
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 9. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
    Galovičová A, Lazúrová I, Petrášová D.
    Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
    Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K.
    Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
    [Abstract] [Full Text] [Related]

  • 12. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function.
    Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto T, Kohno M, Hirosue Y, Goto T.
    Am J Nephrol; 2006 Aug; 26(5):476-82. PubMed ID: 17095862
    [Abstract] [Full Text] [Related]

  • 13. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A, Shima K, Fukuda M, Tahara Y, Yamamoto Y, Kumahara Y.
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [Abstract] [Full Text] [Related]

  • 14. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 15. Further evidence for tubular dysfunction in insulin dependent diabetes.
    Ratzmann KP, Schimke E, Jung K, Pergande M.
    J Diabet Complications; 1989 Nov; 3(3):167-71. PubMed ID: 2528561
    [Abstract] [Full Text] [Related]

  • 16. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ, Li BL, Wang SB, Chen ML, Deng RT, Ye CQ, Liu L, Fang AJ, Xiong SL, Wen S, Tang HH, Chen ZX, Huang ZH, Peng LF, Zheng L, Wang Q.
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [Abstract] [Full Text] [Related]

  • 17. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A.
    Ren Fail; 2006 Jan; 28(2):125-8. PubMed ID: 16538969
    [Abstract] [Full Text] [Related]

  • 18. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.
    Clin Exp Pharmacol Physiol; 2006 Jan; 33(1-2):95-101. PubMed ID: 16445706
    [Abstract] [Full Text] [Related]

  • 19. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
    Titan SM, Vieira JM, Dominguez WV, Moreira SR, Pereira AB, Barros RT, Zatz R.
    J Diabetes Complications; 2012 Jan; 26(6):546-53. PubMed ID: 22981148
    [Abstract] [Full Text] [Related]

  • 20. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR, Lee YH, Lee SG, Kang ES, Cha BS, Lee BW.
    Cardiovasc Diabetol; 2017 Jan 26; 16(1):16. PubMed ID: 28122570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.